Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL5017115

CCN1CCCC1C(=O)O.N

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.44
ACE P12821 7/20 0.44
REN P00797 3/20 0.44
LMNA P02545 2/20 0.44
HSD17B10 Q99714 2/20 0.44
CYP2C19 P33261 2/20 0.44
KDM4E B2RXH2 1/20 0.44
F2 P00734 1/20 0.44
LTA4H P09960 1/20 0.44
MAPT P10636 1/20 0.44
PEPD P12955 1/20 0.44
ALOX15 P16050 1/20 0.44
PTGS1 P23219 1/20 0.44
HTR2A P28223 1/20 0.44
PTGS2 P35354 1/20 0.44
HRH1 P35367 1/20 0.44
THPO P40225 1/20 0.44
PMP22 Q01453 1/20 0.44
ACE2 Q9BYF1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL151570 0.98 ALDH1A1 (0.47) ALDH1A1L3MBTL1ACERENLMNA
SCHEMBL2275704 0.98 ALDH1A1 (0.47) ALDH1A1L3MBTL1ACERENLMNA
SCHEMBL151569 0.98 ALDH1A1 (0.47) ALDH1A1L3MBTL1ACERENLMNA
Hydrochloric Acid SCHEMBL9148101 0.96 ALDH1A1 (0.46) ALDH1A1L3MBTL1ACERENLMNA
Lithium SCHEMBL593022 0.96 ALDH1A1 (0.46) ALDH1A1L3MBTL1ACERENLMNA
Hydrochloric Acid SCHEMBL9432225 0.96 ALDH1A1 (0.46) ALDH1A1L3MBTL1ACERENLMNA
SCHEMBL593020 0.96 ALDH1A1 (0.46) ALDH1A1L3MBTL1ACERENLMNA
SCHEMBL5434462 0.92 SMN1; SMN2 (0.49) ALDH1A1L3MBTL1ACERENLMNA
SCHEMBL315372 0.92 SMN1; SMN2 (0.49) ALDH1A1L3MBTL1ACERENLMNA
SCHEMBL2158601 0.92 SMN1; SMN2 (0.49) ALDH1A1L3MBTL1ACERENLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1513871-B1 PYRROLIDINYL PEPTIDE NUCLEIC ACIDS ISIS INNOVATION (GB) 2008-10-29 EP disclosed
US-7098321-B2 Homologous peptide nucleic acids ISIS INNOVATION LIMITED (GB) 2006-08-29 US disclosed
EP-1513871-A2 PYRROLIDINYL PEPTIDE NUCLEIC ACIDS Isis Innovation Limited (GB) 2005-03-16 EP disclosed
US-6716961-B2 Chiral peptide nucleic acids with a N-aminoethyl-d-proline backbone ISIS INNOVATION LIMITED (GB) 2004-04-06 US disclosed
US-20030228588-A1 Homologous peptide nucleic acids ISIS INNOVATION LIMITED 2003-12-11 US disclosed
US-20030162699-A1 Chiral peptide nucleic acids with a n-aminoethyl-d-proline backbone ISIS INNOVATION LIMITED (GB) 2003-08-28 US disclosed
US-20030157500-A1 Pyrrolidinyl peptide nucleic acids ISIS INNOVATION LIMITED (GB) 2003-08-21 US disclosed
WO-2003066902-A2 PYRROLIDINYL PEPTIDE NUCLEIC ACIDS ISIS INNOVATION LIMITED (GB) 2003-08-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030157500-A1 Pyrrolidinyl peptide nucleic acids POLRMT, POLH, PCNA ALDH1A1 3987/4885L3MBTL1 554/4885ACE 3500/4885
US-20030162699-A1 Chiral peptide nucleic acids with a n-aminoethyl-d-proline backbone POLL, HNRNPL, RNGTT ALDH1A1 4356/4885L3MBTL1 461/4885ACE 391/4885
US-20030228588-A1 Homologous peptide nucleic acids HNRNPH3, PCNA, POLL ALDH1A1 3963/4885L3MBTL1 305/4885ACE 3394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.